- HUAWEI has revealed a continuous glucose monitor in China.
- HUAWEI Sence G1 is the company’s first-ever Class III medical device.
- HUAWEI hasn’t shared details about availability but said it has been in development for over three years.
HUAWEI may have been nearly wiped out of international markets by sanctions imposed on it during the first tenure of US President Donald Trump, but it remains at the top of China’s leaderboard. Along with its innovations across slab phones, foldables, and laptops—including laptops with foldable screens —HUAWEI also offers a broad range of wearables, including ones that monitor blood pressure. So far, the lineup has only comprised smartwatches and fitness bands, but HUAWEI is now adding a health-centric utility in the form of a glucose monitor.
The HUAWEI Sence G1 is the company’s first continuous glucose monitor (CGM). The device works alongside other HUAWEI products, allowing users to view glucose levels on their phones, a smartwatch, or a HUAWEI fitness band. Besides monitoring a user’s glucose levels, the CGM will also alert them in case of any unusual spikes or dips.
